FTRE · Healthcare · $1.9B
$19.95+1.06%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“수주 잔고 배율(book-to-bill) 1.15배로 3분기 연속 1.1배 이상을 기록했어요 — 이전 분기도 1.1배 이상이었는데 이번엔 바이오”
In the company's words · 2026 1분기 earnings call